Healthcare - Biotechnology - NASDAQ - US
$ 1.235
-9.85 %
$ 58.9 M
Market Cap
-0.67
P/E
CASH FLOW STATEMENT
-81.2 M
OPERATING CASH FLOW
111 M
INVESTING CASH FLOW
48.6 M
FINANCING CASH FLOW
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis
Shattuck Labs, Inc.
| Net Income | -87.3 M |
| Depreciation & Amortization | 4.04 M |
| Capital Expenditures | -407 K |
| Stock-Based Compensation | 6.94 M |
| Change in Working Capital | -4.1 M |
| Others | 718 K |
| Free Cash Flow | -81.6 M |
Cash Flow
Millions
| Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | Dec-2018 | |
|---|---|---|---|---|---|---|
| OPERATING CASH FLOW | ||||||
| Net Income | (87.3) | (101.9) | (45.0) | (36.6) | (24.0) | (7.4) |
| Depreciation & Amortization | 4.0 | 3.1 | 1.4 | 0.6 | 0.5 | 0.3 |
| Deferred Income Tax | 0 | 0 | 3.0 | 1 K | (0.2) | (0.4) |
| Stock Based Compensation | 6.9 | 6.5 | 5.5 | 1.3 | 0.5 | 0.4 |
| Other Operating Activities | (0.8) | 2.4 | 1.5 | 89 K | 41 K | 2.7 |
| Change in Working Capital | (4.1) | (4.5) | (23.5) | 1.0 | 2.2 | (2.5) |
| Cash From Operations | (81.2) | (94.5) | (57.1) | (33.7) | (21.0) | (6.9) |
| INVESTING CASH FLOW | ||||||
| Capital Expenditures | (0.4) | (11.6) | (7.9) | (0.7) | (0.5) | (1.2) |
| Other Items | 111.3 | 61.1 | (2.5) | (145.6) | (3.1) | (28.7) |
| Cash From Investing Activities | 110.9 | 49.4 | (10.4) | (146.3) | (3.6) | (29.9) |
| FINANCING CASH FLOW | ||||||
| Common Stock Repurchased | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Debt Repaid | 0 | 0 | 0 | 0 | 0 | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | 0.4 | 0.2 | 1.9 | 98.6 | 64 K | 35.1 |
| Cash From Financing Activities | 48.6 | 0.2 | 1.9 | 330.9 | 64 K | 35.1 |
| CHANGE IN CASH | ||||||
| Net Change In Cash | 78.2 | (44.9) | (65.6) | 150.9 | (24.6) | (1.7) |
| FREE CASH FLOW | ||||||
| Free Cash Flow | (81.6) | (106.1) | (65.0) | (34.4) | (21.4) | (8.1) |